David Pernock Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Pernock.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Pernock. David Pernock is Chairman and CEO in Fibrocell Science, Inc. ($FCSC) and Chief Executive Officer in Fibrocell Science, Inc. ($FCSC) and Director in Fibrocell Science, Inc. ($FCSC) and Director in EAGLE PHARMACEUTICALS, INC. ($EGRX) and Pres & Chief Operating Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX) and Pres. & Chief Comm. Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX).

Latest Insider Trading Transactions of David Pernock

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, EGRX, FCSC

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...GrantA0.009,700054,62544.9 K to 54.6 K (+21.59 %)
Jan 26 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF47.701,89290,24844,92546.8 K to 44.9 K (-4.04 %)
Jan 11 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF50.9790646,17946,81747.7 K to 46.8 K (-1.90 %)
Jan 07 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF50.022,088104,44247,72349.8 K to 47.7 K (-4.19 %)
Jan 27 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF57.981,793103,95849,81151.6 K to 49.8 K (-3.47 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA59.8051,0003,049,54551,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF57.3890451,87251,60452.5 K to 51.6 K (-1.72 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0021,500052,50831 K to 52.5 K (+69.34 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA42.4046,6001,975,84046,600
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0020,900031,00810.1 K to 31 K (+206.77 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF41.3385835,46110,10811 K to 10.1 K (-7.82 %)
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA0.0030,000030,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA59.1450,0002,957,00050,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0010,000010,966966 to 11 K (+1,035.20 %)
May 19 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP79.6925520,321966711 to 966 (+35.86 %)
May 16 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP82.2420016,448711511 to 711 (+39.14 %)
Mar 21 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP83.98615,123511450 to 511 (+13.56 %)
Mar 10 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP77.8445035,0284500 to 450
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA84.9290,0007,642,80090,000
Dec 02 2016FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP0.9250,00046,085105,60055.6 K to 105.6 K (+89.93 %)
Mar 02 2016FCSCFibrocell Science, ...Pernock DavidChairman and CEOOption ExerciseA2.27425,000964,750425,000
Jan 05 2016EGRXEAGLE PHARMACEUTIC ...Pernock DavidDirectorOption ExerciseA86.1515,0001,292,25015,000
Nov 13 2015FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP5.003,00014,99755,60052.6 K to 55.6 K (+5.70 %)
Aug 11 2015FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP6.543,50022,89052,60049.1 K to 52.6 K (+7.13 %)
May 13 2015FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP4.3015,00064,48549,10034.1 K to 49.1 K (+43.99 %)
May 13 2015FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP4.291,6006,86234,10032.5 K to 34.1 K (+4.92 %)
Apr 22 2015EGRXEAGLE PHARMACEUTIC ...Pernock DavidDirectorOption ExerciseA59.3115,000889,65015,000
Apr 10 2015EGRXEAGLE PHARMACEUTIC ...Pernock DavidDirectorOption ExerciseA46.8110,000468,10010,000
Apr 10 2015EGRXEAGLE PHARMACEUTIC ...Pernock DavidDirectorOption ExerciseA46.8110,000468,10010,000
Dec 15 2014FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP2.525,00012,60032,50027.5 K to 32.5 K (+18.18 %)
Nov 21 2014FCSCFibrocell Science, ...Pernock DavidChairman and CEOBuyP2.545,00012,68627,50022.5 K to 27.5 K (+22.22 %)
Jun 06 2014FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...BuyP2.9512,50036,92522,50010 K to 22.5 K (+125.00 %)
Nov 21 2013FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...BuyP3.6910,00036,90010,0000 to 10 K
Nov 18 2013FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...Option ExerciseA3.40800,0002,720,0001,203,000
Jul 23 2013FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...Option ExerciseA5.49175,000960,750403,000
Apr 12 2011FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...Option ExerciseA0.821,500,0001,230,0005,700,000
Jan 18 2011FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...Option ExerciseA0.622,100,0001,302,0004,200,000
Feb 03 2010FCSCFibrocell Science, ...Pernock DavidChief Executive Off ...Option ExerciseA1.081,650,0001,782,0002,100,000
Oct 02 2009FCSCFibrocell Science, ...Pernock DavidDirectorOption ExerciseA0.75450,000337,500450,000

Page:   1

Contact us | Follow us on Twitter